Cell adhesion molecules and adhesion abnormalities in prostate cancer

Critical Reviews in Oncology/Hematology

Volumn 41, Issue 1, 2002, Pages 11-28

  Mason, Malcolm D ^a   Davies, Gaynor ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

catenin; Cadherin; Cell adhesion; Prostate cancer

Indexed keywords

BETA CATENIN; CADHERIN; CATENIN; CELL ADHESION MOLECULE; IMMUNOGLOBULIN; PROTEIN P120; SELECTIN;

CANCER INCIDENCE; CELL ADHESION; CELL FUNCTION; CELL GROWTH; DISEASE COURSE; GENE EXPRESSION; HUMAN; MALE; METASTASIS; PROGNOSIS; PROSTATE CANCER; PROTEIN FAMILY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; URINARY TRACT CANCER;

ANIMALS; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; DISEASE PROGRESSION; HUMANS; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS;

EID: 0036143842     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(01)00171-8     Document Type: Review

References (164)

1. The result of prostate carcinoma screening in the US as reflected in the surveillance, epidemiology, and end results program
2. Tumor invasion and metastases. Biochemical mechanisms
3. Molecular aspects of the metastatic cascade
4. The molecular and cellular basis of cancer invasion and metastasis and its implications for treatment
5. The cadherins. cell-cell adhesion molecules controlling animal morphogenesis
6. Cadherin cell adhesion receptors as a morphogenetic regulator
7. Cellular adhesion molecules in urologic malignancies
8. Role of alpha II (b) beta 3 integrin in prostate cancer metastasis
9. E-cadherin and its associated protein catenins, cancer invasion and metastasis
10. Uvomorulin. A non integral membrane protein of early mouse embryo
11. Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody, Anti-Arc1. Mechanistic aspects and identifications of the antigen as a component related to uvomorulin
12. Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin
13. Focal adhesion kinase and associated proteins
14. Sphingosine induces p125FAK and paxillin tyrosine phosphorylation, actin stress fiber formation, and focal contact assembly in Swiss 3T3 cells
15. The role of integrin mediated processes in the biology of metastasis
16. Tight junctions, a critical structure in the control of cancer invasion and metastasis
17. Tight junctions and the molecular basis for regulation of paracellular permeability
18. Molecular dissection of tight junctions
19. Structural basis of cell-cell adhesion by cadherins
20. Structural basis of calcium-induced E-cadherin regidification and dimerization
21. Localization of specificity determining sites in cadherin cell adhesion molecules
22. From cadherins to catenins. Cytoplasmic protein interaction and regulation of cell adhesion
23. Molecular cloning of human E-cadherin suggests a novel subdivision of the cadherin superfamily
24. Diversity of the cadherin family. Evidence for eight new cadherins in nervous tissue
25. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas
26. Cadherins and associated proteins
27. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species
28. E-cadherin and its associated protein catenins, cancer invasion and metastasis
29. Cell binding function of E-cadherin is regulated by the cytoplasmic domain
30. The uvomorulin-anchorage protein α-catenin is a vinculin homologue
31. The 102 Kd cadherin-associated protein. Similarity to vinculin and post-transcriptional regulation of expression
32. cas associates with E-cadherin complexes
33. The E-cadherin complex contains the src substrate p120
34. Purification of a 92kDa cytoplasmic protein tightly associated with the cell-cell adhesion molecule E-cadherin (uvomorulin) characterisation and extractability of the protein complex from the cell cyto-structure
35. src substrate upon epidermal growth factor and platelet-derived growth factor receptor stimulation and in polyomavirus middle-T-antigen-transformed cells
36. src transformation-associated substrate
37. Molecular analysis of armadillo locus. Uniformly distributed transcripts and a protein with novel internal repeats are associated with a Drosophila segment polarity gene
38. The segment polarity gene armadillo encodes a functionally modular protein that is the Drosophila homolog of human plakoglobin
39. A repeating amino acid motif shared by proteins with diverse cellular roles
40. Cadherin-deendent cell aggregatin is affected by decapeptide drived from rat extracellular super-oxide dismutase
41. The E-cadherin/catenin complex in invasion. the role of ectodomain shedding
42. 2+)-dependent cell-cell adhesion
43. Dynamics of cadherin/catenin complex formation. Novel protein interactions and pathways of complex assembly
44. Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells
45. Identification of plakoglobin domains required for association with N-cadherin and γ-catenin
46. Association of the APC gene product with β-catenin
47. Association of the APC tumour suppressor protein with catenins
48. E-cadherin and APC compete for the interaction with beta-catenin and the cyto-skeleton
49. Association of plakoglobin with APC, a tumour suppressor gene product and its regulation by tyrosine phosphorylation
50. Wingless signalling. The inconvenient complexities of life
51. Wingless signal and zest white 3 kinase trigger opposing changes in the intracellular distribution of armadillo
52. Expression of E-cadherin, α-, β- and γ-catenin in human colorectal cancer
53. 2+)-dependent cell-cell adhesion
54. Cadherin dysfunction in a human cancer cell line. possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness
55. Reduction of E-cadherin levels and deletion of the α-catenin gene in human prostate cancer cells
56. Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the β-cetenin gene in a human cancer cell line, HSC-39
57. Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts
58. Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells
59. Expression of β-catenin and gamma-catenin in epithelial tumor cell lines and characterization of a unique cell line
60. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin
61. β-catenin is a target for the ubiquitin-proteasome pathway
62. Bridging of β-catenin and gluycogen synthase kinase-3β by axin and inhibitionof β-catnin mediated transcription
63. Casein kinase I epsilon in the Wnt pathway: regulation of β-catenin function
64. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3
65. Identification of a brain specdific APC homologue, APCL, and its interaction with β-catenin
66. Biochemical interactions in the wnt pathway
67. Nuclear endopoint of wnt signalkling. Neoplastic transformation induced by transactivating lymphoid-enhancing factor 1
68. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly
69. Casein kinase I transduces wnt signals
70. Wnt-induced dephosphorylation of Axin releases β-catenin from the Axin complex
71. Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains
72. 2+ binding site of uvomorulin abolish adhesive function
73. Target genes of β-catenin T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas
74. Identification of c-MYC as a target of the APC pathway
75. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
76. Regulation of β-catenin transformation by the p300 transcriptional coactivator
77. The wnt/wg signal transducer β-catenin controls fibronectin expression
78. The TKA1-NLK-MAPK related pathway antagonizes signalling between β-catenin and transcriptin factor TCF
79. Drosophila TCF and Groucho interact to repress wingless signalling activity
80. A functional interaction between the histone deacetylase Rpd3 and the corepressor groucho in drosophila development
81. Pontin52 and reptin52 function as antagonistic regulators of beta-catenin signalling activity
82. β-catenin regulates the expression of the matrix metalloproteinase 7 in human colorectal cancer
83. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors
84. Down regulatin of monocyte chemotactic protein-3 by activated β-catenin
85. Structural and functional identification o ftwo human tumor derivd monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family
86. Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein 3 (MCP-3) gene transfer: perivasclar accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment witin the tumor
87. Association of p120, a tyrosine inase substrate, with E-cadherin/catenin complexes
88. The p120 catenin family: complex roles in adhesion, signalling and cancer
89. Nuclear localisation of the p120ctn armadillo-like catenin in counteracted by a nuclear export signal and by E-cadherin expression
90. ARVCF localizes to the nucleus and adherens junction and is mutually exclusive with p120ctn in E-cadherin complex
91. kip1, a cyclin-CDK inhibitor, links transforming growth factor β and contact inhibition to cell cycle arrest
92. Translational control of p27kip1 accumulation during theh cell cycle
93. A cell cycle-regulated inhibitor of cyclin-dependent kinases
94. kip1
95. Truncation of the β-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution
96. Functional domains of α-catenin required for the strong state of cadherin-based cell adhesion
97. Involvement of adenomatous polyposis coli (APC)/β-catenin signalling in human breast cancer
98. Hepatocyte growth factor/scatter factor disrupts E-cadherin mediated cell-cell adhesion by induction of the phosphorylation of β-catenin
99. The small GTPases rho and rac are required for the establishment of cadherin-dependent cell-cell contacts
100. Inhibition of invasion of epithelial cells by Tiam1-Rac signalling
101. Regulation of cadherin-mediated cell-cell adhesion by the Rho family GTPases
102. Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin
103. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer
104. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer
105. E-cadherin. A marker for differentiation and invasiveness in prostatic carcinoma
106. E-cadherin expression in prostatic carcinoma biopsies. Correlation with tumour grade, DNA content, pathological stage and clinical outcome
107. Expression of E-cadherin in primary and metastatic prostate cancer
108. Expression of E-cadherin and alpha-, beta- and gamma-catenins in human blaader carcinomas. Are they good prognostic factors?
109. E-cadherin and alpha-, beta- and gamma catenin expression in prostate cancers. correlation with tumour invasion
110. Alpha-catenin expression has a prognostic value in local and locally advanced prostate cancer
111. Cell-cell adhesion and signalling intermediates in human prostate cancer
112. Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma. Close association with advanced disease stage and lymph node metastasis
113. Prognostic value of CD44 standard, variant isoforms 3 and 6 and alpha-catenin expression in local prostate cancer treated by radical prostatectomy
114. Relationship between E-cadherin expression and lymph node metastasis in human oesophageal cancer
115. TI Expression of cadherins and catenins in paired tumor and non-neoplastic primary prostate cultures and corresponding prostatectomy specimens
116. Aberrant E-cadherin and alpha-catenin expression in prostate cancer. Correlation with patient survival
117. Immunoexpression of E-cadherin and beta-catenin correlates to survival of patients with hepatocellular carcinomas
118. Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer. Implications for cell adhesion and signalling
119. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice
120. Beta-catenin affects androgen receptor transcriptional activity and ligand specificity
121. Changing views of the role of matrix metalloproteinases in metastasis
122. Matrix metalloproteinases in tumour invasion and metastasis
123. Matrilysin in early stage intestinal tumorigenesis
124. Matrilysin. An epithelial matrix metalloproteinase with potentially novel functions
125. Promatrilysin expression is induced by fibroblast growth factors in the prostatic carcinoma cell lines LNCap but not in normal primary prostate epithelial cells
126. MMP inhibition in prostate cancer
127. Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostateM
128. Enhanced production and activation of matrix metalloproteinases-7 (matrilysin) in human endometrial carcinomas
129. Matrilysin as a target for chemotherapy for colon cancer. Use of antisense oligonucleotide as antimetastatic agents
130. Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection
131. Soluble forms of the adhesion molecule E-cadherin in urine
132. Serum concentrations of soluble adhesion molecules in patients with colorectal cancer
133. Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule- (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer
134. A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis
135. Cadherins in cancer. Implications for invasion and metastasis
136. Dissecting tumour cell invasion. Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion
137. Cell-cell contacts mediated by E-cadherin (uvomorulin) restrict invasive behaviour of L-cells
138. E-cadherin mediated cell-cell adhesion prevents invasiveness of human carcinoma cells
139. Downregulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice
140. E-cadherin expression in colorectal cancer
141. Mechanims of inactivation of E-cadherin in breast cancer cell lines
142. Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast
143. Silencing of the E-cadherin invasive-suppressor gene by CpG methylation in human carcinomas
144. E-cadherin expression is silenced by 5′ CpG island methylation in acute leukaemia
145. Altered expression of E-cadherin in gastric cancer tissue and carcinomatous fluid
146. Soluble E-cadherin fragments increased in circulation of cancer patients
147. Cell adhesion molecules in bladder cancer. Soluble serum E-cadherin correlates with predictors of recurrence
148. Characterization of soluble E-cadherin as a disease marker in gastric cancer patients
149. Soluble fragments of E-cadherin cell adhesion molecule vincrease in urinary excretion of cancer patients, potentially indicating its shedding from epithelial tumour cells
150. Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies
151. Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer
152. Identification and purification of a cell surface glycoprotein mediating intercellular adhesion in embryonic and adult tissue
153. Assays for measuring soluble cellular adhesion molecules and soluble cytokine receptors
154. Cleavage of β-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis. Evidence for a role of caspases and metalloproteinases
155. Sandwich enzyme immunoassay for serum integrins using monoclonal antibodies
156. Soluble intercellular adhesion molecule-1 in colorectal cancer and its relationship to acute phase proteins
157. Soluble CD44 molecules in serum of patients with prostate cancer and benign prostatic hyperplasia
158. Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases
159. Cadherin switching in human prostate cancer progression
160. Complex cadherin expression in human prostate cancer cells